20/20 BIOLABS, INC.: noncurrent_liabilities
| Value | {"amount": 723848, "concept": "us-gaap:LiabilitiesNoncurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2024-12-31) |
| Status | current |
| Entity | 20/20 BIOLABS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:27:01.038089+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ac428bfe-2b21-4d8e-8f2b-84c679b9cbf5
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-26-037667 · Open the official SEC filing →Retrieved: 2026-08-19T11:27:01.038089+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001139685/noncurrent-liabilities/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ac428bfe-2b21-4d8e-8f2b-84c679b9cbf5
History
- no predecessors — first report